Skip to main content
David Klonoff, MD, Endocrinology, Burlingame, CA, UCSF Medical Center

DavidC.KlonoffMDFACP, FRCP (Edin), Fellow AIMBE

Endocrinology • Burlingame, CA

Diabetes, Lipid Metabolism

Clinical Professor of Medicine, UCSF

Join to view full profile

Dr. Klonoff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Klonoff's full profile

Already have an account?

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Endocrinology, Diabetes, and Metabolism, 1978 - 1981
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1978 - 1979
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1976 - 1978
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 1976
  • University of California, Berkeley
    University of California, BerkeleyBS, Genetics, With Highest Honors, 1968 - 1972

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1977 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Conformity Assessment Award IEEE, 2022
  • Outstanding Physician Clinician Award American Diabetes Association, 2019
  • Director’s Citation Award for outstanding contributions to the Center for Devices and Radiological Health related to diabetes technology FDA, 2010
  • Join now to see all

Press Mentions

  • 'The More Data ... The Better': AI Poised to Alter Diabetes Care
    'The More Data ... The Better': AI Poised to Alter Diabetes CareApril 17th, 2023
  • Glycemia Risk Index Provides New Tool for Assessing Glycemic Control with CGM Data
    Glycemia Risk Index Provides New Tool for Assessing Glycemic Control with CGM DataApril 12th, 2022
  • Destination Guam: Why Top Diabetes Doctors and an AI Company Are Headed to the Pacific Island?
    Destination Guam: Why Top Diabetes Doctors and an AI Company Are Headed to the Pacific Island?September 21st, 2021
  • Join now to see all

Professional Memberships

Hospital Affiliations

Dr. David Klonoff, Dr. David Klonoff, MD, Dr. D Klonoff, Dr. David C. Klonoff